Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Focused ultrasound is not one Parkinson’s treatment. In the United States, FDA-cleared use depends on the brain target and the problem being treated: unilateral thalamotomy for medication-resistant tremor-dominant Parkinson’s disease, or lesioning of the pallidothalamic pathway for advanced Parkinson’s with medication-refractory motor complications. The procedure makes a small, permanent thermal brain lesion without an incision or implanted lead, so candidacy and risk must be assessed case by case by a movement-disorders specialist.
Here is how the indications differ, what screening involves, what the evidence actually shows, which risks to discuss, and what recovery questions to ask before deciding.
What focused ultrasound treats in Parkinson’s disease
“Focused ultrasound for Parkinson’s” describes magnetic-resonance-guided focused ultrasound (MRgFUS), not a single universal procedure. Ultrasound energy is concentrated on a chosen brain target while MRI provides anatomical guidance and temperature monitoring. The target determines which symptom the treatment is intended to change.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitches| FDA pathway in the United States | Target and procedure | Who it is intended for | What it aims to treat |
|---|---|---|---|
| Tremor-dominant Parkinson’s disease | Unilateral thalamotomy of the ventral intermediate (VIM) target | Adults aged 30 or older with specialist-confirmed tremor-dominant Parkinson’s disease, disabling tremor despite optimal medication, or inability to tolerate medication for other cardinal symptoms | Disabling Parkinson’s tremor, generally on the treated side of the body |
| Advanced idiopathic Parkinson’s disease with motor complications | Unilateral pallidothalamic tractotomy under the July 3, 2025 FDA PMA supplement (other applicable labeling may describe pallidotomy) | Adults aged 30 or older with advanced idiopathic Parkinson’s disease and medication-refractory moderate-to-severe motor complications, assessed by a movement-disorders neurologist or specialist | Selected medication-resistant motor complications, not the entire progression of Parkinson’s disease |
The FDA’s 2025 supplement also permits staged treatment of the opposite side at least six months after the first procedure when contralateral motor complications remain medication-refractory and that side has not previously been treated. That is a separate decision, not an automatic second session.
#1 Best Overall
- Portable Joint Care Device: This compact massager hand-held is a simple personal-care tool for non-invasive joint care and daily muscle comfort. Use it at home, in the office, after physical activity, or while traveling.
- Focused Comfort: Designed for targeted use around the knees, elbows, wrists, ankles, neck, shoulders, back, hands, and feet. This back massager handheld supports convenient everyday comfort.
- User-Friendly Design: Choose low, medium, or high intensity to match your preferred comfort level. This hand held back massager comes with an ergonomic grip and simple touch control which makes sessions easy to manage for relaxation and everyday wellness.
- Travel-Ready Convenience: Lightweight and easy to store, this body massager handheld design is made for simple handling and daily application. The corded design uses the included power adapter without requiring battery recharging.
- Everyday Personal Care: This compact massager handheld device provides convenient joint-area comfort and muscle relaxation. It is designed as a simpler alternative to bulky massage devices and is not an ultrasound device.
A lesion in one target does not cure Parkinson’s disease, stop its underlying progression, or treat every symptom. Speech, cognition, autonomic symptoms, gait, balance, rigidity, dyskinesia and tremor can respond differently. Your clinician should identify the single most disabling problem and the matching target before discussing expected benefit.
Am I a candidate?
Diagnosis alone does not establish eligibility. A center usually combines a movement-disorders assessment, medication history, MRI and CT screening, and a review of whether you can safely complete an awake, prolonged MRI-guided procedure.
Clinical requirements
- Correct indication: The tremor pathway requires specialist-confirmed tremor-dominant disease with disabling, medication-resistant tremor or medication intolerance. The motor-complication pathway requires advanced idiopathic Parkinson’s disease with moderate-to-severe complications that remain refractory despite medication.
- Age: The current FDA indications described above specify age 30 or older.
- Specialist assessment: A movement-disorders neurologist determines whether the symptom pattern, disease stage and medication response fit the indication.
- Realistic treatment goal: The target must correspond to the symptom you most want to improve. A procedure aimed at tremor should not be presented as treatment for every Parkinson’s symptom.
MRI, skull and positioning screening
- You must be able to tolerate MRI and remain still for an extended period while communicating sensations to the treatment team.
- Imaging must show that the intended target can be identified and safely reached.
- CT-based skull-density screening is used because skull shape and density affect how efficiently ultrasound enters and focuses in the brain. FDA labeling describes an overall skull-density-ratio threshold; the center calculates whether your anatomy meets its requirements.
- The team checks all implants and devices for MRI compatibility and reviews prior cranial procedures, including deep-brain stimulation.
Medical and safety screening
FDA prescriber information identifies concerns that can make treatment unsafe or unsuitable. The complete current labeling and your medical record control the final decision, but screening commonly addresses:
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
- Non-MRI-compatible implants or other standard MRI contraindications
- Pregnancy
- Advanced kidney disease or dialysis, when MRI contrast or the overall procedure presents a concern
- Unstable cardiac disease or severe uncontrolled hypertension
- Bleeding disorders, coagulopathy, or use of anticoagulant or other hemorrhage-risk drugs within the relevant one-month window
- Cerebrovascular disease, prior stroke or brain hemorrhage, or a brain tumor
- Unstable psychiatric disease or uncontrolled depressive symptoms
- Substance-abuse behaviors that could compromise safety
- Inability to tolerate prolonged stationary positioning
The patient guide also advises discussing substantial scalp scarring, seizure history, previous deep-brain stimulation and any bleeding condition. Those educational points reflect an earlier tremor-dominant labeling context, so they supplement rather than replace the current prescriber information for your indication.
How the procedure works
Planning and treatment
- You lie inside an MRI scanner with your head secured so the system can map your anatomy and keep the target aligned.
- The team uses MRI and CT information to plan the ultrasound path and confirm that the skull will transmit and focus the energy adequately.
- Low-energy test sonications may be used to check targeting and monitor your responses. You remain awake and communicate sensations or new symptoms.
- When the target is confirmed, higher-energy sonications raise its temperature enough to destroy a small volume of tissue. MRI thermometry monitors heating during treatment.
- The team checks neurological function and imaging before ending the session and gives you indication-specific observation and follow-up instructions.
What “noninvasive” means here
The FDA-hosted Exablate Neuro Patient Guide USA explains: “Ultrasound is a form of sound energy that passes through skin, muscle, fat, and bone without the need for incisions, electronic leads, or inserted probes.” In practical terms, there is no scalp incision, burr hole, implanted lead or inserted brain probe.
Rank #2
- Light Weight Easy To Oprate
That does not mean the treatment is harmless or reversible. Ultrasound intentionally heats and destroys brain tissue, creating a permanent lesion. Risks therefore include effects from inaccurate targeting, heat spreading to nearby structures, bleeding and other neurological complications even though the skin is not opened.
What evidence supports benefit?
The most clearly quantified Parkinson’s result comes from a small, target-specific trial rather than a general success rate for all focused-ultrasound patients.
The 2018 sham-controlled tremor trial
In a two-center, double-blind, sham-controlled pilot randomized trial published in JAMA Neurology in 2018, 27 people with medication-refractory tremor-dominant Parkinson’s disease were randomized: 20 received unilateral focused-ultrasound thalamotomy and seven received a sham procedure. At three months, treated-hand tremor scores improved by a median of 62% in the treatment group versus 22% after sham; the difference between groups was statistically significant.
That 62% figure applies only to the study’s small cohort, its unilateral thalamic target, its medication-refractory tremor population and its three-month assessment. It is not a guaranteed result for an individual, an estimate for pallidothalamic tractotomy, or a percentage for every Parkinson’s symptom.
The available sources do not establish a population-wide probability of benefit, a reliable personalized prediction, or a comprehensive recovery-time statistic. Ask the treating center what evidence applies to your exact indication, target and disease stage.
Rank #3
- Light Weight Easy To Oprate
Risks and side effects to discuss
Risk depends on the target, the ultrasound path, skull anatomy, underlying health and the experience of the treating team. A unilateral lesion also creates a different risk-benefit balance from bilateral treatment.
Events reported in the tremor trial
The 2018 trial reported paresthesia (abnormal tingling or numbness) and ataxia (impaired coordination). Two participants developed mild hemiparesis associated with capsular heating, and some sensory or balance effects persisted at follow-up. Headache and dizziness or vertigo related to the MRI/ultrasound environment were reported but resolved by the end of the procedure in that trial.
These findings are historical data from a small thalamotomy study. They do not provide a universal current percentage for the newer pallidothalamic tractotomy indication. Your clinician should explain the target-specific adverse-event profile in the current FDA labeling and the center’s consent materials.
Important risk categories
- Neurological effects: weakness, numbness, imbalance, coordination problems, speech changes or other deficits if nearby pathways receive unintended heat.
- Persistent symptoms: Some sensory or balance effects can last beyond the procedure; a lesion’s effects cannot simply be switched off.
- MRI and positioning problems: claustrophobia, discomfort, headache, vertigo, skin pressure or inability to remain still can interrupt treatment.
- Bleeding and medical complications: Although there is no incision, your bleeding risk, blood pressure, cardiovascular status and medication list still matter.
- Incomplete or uneven benefit: The treated symptom may improve only partly, may not improve, or may not remain controlled as Parkinson’s disease changes.
Seek urgent instructions from your center for new weakness, severe or worsening headache, confusion, seizure, persistent vomiting, trouble speaking, sudden vision changes or rapidly worsening balance after treatment. Use the center’s emergency number rather than waiting for a routine follow-up if those symptoms occur.
How long does recovery take?
No universal recovery timeline is established by the cited sources. The procedure involves prolonged positioning and MRI-guided lesioning, but observation time, discharge timing, driving restrictions, activity limits, medication changes and follow-up imaging vary by indication, patient health and local protocol.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Rank #4
- ♥Ultrasound Therapy for Home Use: Designed for convenient at-home body care, this handheld ultrasound therapy device helps support relaxation and targeted comfort for areas such as the back, shoulders, arms, legs, and other muscles after daily activity or exercise.
- ♥Multiple Pain Relief Functions: Effectively treats shoulder pain, calcific tendonitis, radial/ulnar epicondylitis, trochanteric tendonitis, waist or stern pain, patellar tendonitis, tibial stress syndrome, achillodynia, plantar fasciitis, and supports E‑D therapy
- ♥Portable & Quiet : Compact, lightweight design with low‑noise operation for home, office, gym, spa, or salon. Simple controls make it convenient to use anywhere.
- ♥Customer Support: Please contact us with any product questions or concerns. We are committed to providing helpful support and a positive customer experience.
- ♥Advanced Shockwave Principle: Electromagnetic pressure waves deliver a rapid rise and gradual release of pressure to stimulate deep tissue and promote circulation for improved comfort and mobility
Questions to get answered before scheduling
- How long should I expect to be in the MRI suite, including planning, test sonications and observation?
- Will I go home the same day, stay overnight, or follow another observation plan?
- When may I drive, exercise, work, fly or resume normal activities?
- Should Parkinson’s medications change before or after treatment, and who makes that decision?
- When are neurological checks, MRI scans and specialist visits scheduled?
- Which symptoms require an emergency call, and whom do I contact after hours?
Do not accept “same-day recovery” or a fixed return-to-work promise without a plan tailored to your target and health. The intended lesion is permanent, while the time course of symptom improvement and side effects can vary.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Focused ultrasound versus medication and DBS
Medication management and deep brain stimulation (DBS) remain recognized Parkinson’s treatment alternatives. The right comparison is not “which procedure is best?” but “which option fits this symptom, this disease stage and this person’s priorities?”
| Decision axis | Focused ultrasound lesioning | Deep brain stimulation | Medication management |
|---|---|---|---|
| How it changes the brain | Creates a permanent, focal thermal lesion | Uses implanted electrodes and a pulse generator to deliver adjustable stimulation | Changes symptoms through systemic medicines |
| Incision or implanted hardware | No incision, inserted probe or implanted lead | Requires neurosurgical implantation and hardware | No brain procedure |
| Adjustability | The lesion cannot be turned off or reprogrammed | Stimulation settings can be adjusted and hardware may be revised | Doses and drugs can be changed, subject to side effects and response |
| Laterality | Typically unilateral; FDA labeling allows staged contralateral pallidothalamic treatment at least six months later for qualifying patients | Can be planned for one or both sides, depending on clinical judgment | Systemic treatment rather than a focal one-sided lesion |
| Key eligibility issues | Target visibility, skull density, MRI safety, ability to remain still and communicate, and indication-specific health screening | Operative fitness, MRI and surgical considerations, cognitive and psychiatric assessment, and willingness to manage hardware | Medication response, side effects, interactions and adherence |
FDA materials note that unilateral lesioning does not address the bilateral nature of Parkinson’s progression. Discuss future flexibility: whether you might later need treatment on the other side, whether an irreversible lesion is acceptable, how MRI access will be handled, and whether you prefer to avoid implanted hardware despite losing adjustability.
Preparing for a specialist consultation
Bring a complete medication list, including anticoagulants, supplements and recent dose changes. Record which symptoms occur when medicines are working and when they wear off. Bring implant cards and prior brain-imaging reports, and tell the team about kidney disease, pregnancy possibility, bleeding history, strokes, seizures, psychiatric symptoms, scalp scars and prior DBS.
Ask the center to state in writing:
- The exact FDA indication and brain target proposed for you
- Which symptom is expected to improve and which symptoms are unlikely to change
- How your CT skull-density result and MRI findings affect eligibility
- Target-specific benefits, adverse events and the possibility of persistent deficits
- The observation, discharge, driving, activity and medication plan
- Follow-up schedule and emergency contact procedure
- What alternatives remain if benefit is incomplete or Parkinson’s progresses
Bottom line for decision-making
Focused ultrasound can be a reasonable option for carefully selected adults with a specific, disabling Parkinson’s problem, but it is not a cure and not a one-size-fits-all treatment. In the United States, tremor-dominant thalamotomy and advanced motor-complication pallidothalamic tractotomy have different targets, evidence and eligibility rules. The procedure avoids an incision and implanted lead while deliberately creating a permanent brain lesion. A movement-disorders specialist and an experienced MRgFUS team should weigh your symptom pattern, medication response, MRI and skull anatomy, medical risks, recovery needs and future treatment choices before you decide.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
